Section Arrow
AFMD.NASDAQ
- Affimed NV
Quotes are at least 15-min delayed:2024/12/24 23:47 EST
Last
 1.24
+0.05 (+4.20%)
Day High 
1.25 
Prev. Close
1.19 
1-M High
3.0982 
Volume 
251.92K 
Bid
1.22
Ask
1.23
Day Low
1.16 
Open
1.2 
1-M Low
1.1438 
Market Cap 
19.51M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.74 
20-SMA 2.19 
50-SMA 2.89 
52-W High 8.95 
52-W Low 1.1438 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.55/-3.02
Enterprise Value
32.49M
Balance Sheet
Book Value Per Share
1.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.28M
Operating Revenue Per Share
2.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3853-0.0178-4.42%-- 
CMNDClearmind Medicine1.72+0.5+40.98%0.16PE
CEROCERo Therapeutics Holdings0.0623+0.0118+23.37%-- 
ATNF180 Life Sciences Corp2.9+1.03+55.08%0.23PE
RXRXRecursion Pharmaceuticals7.24+0.25+3.58%-- 
Quotes are at least 15-min delayed:2024/12/24 23:47 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents anapproach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.